Bath preparation for preventing and treating neonatal jaundice

Abstract

The invention relates to the field of traditional Chinese medicine preparations, in particular to a bath preparation for preventing and treating neonatal jaundice, which is prepared from the following components: 45g of scutellaria baicalensis, 30g of coptis chinensis, 60g of golden cypress, 30g of raw cape jasmine, 90g of oriental wormwood, 30g of raw rhubarb, 90g of dandelion, 30g of fructus forsythiae, 45g of honeysuckle stem and 20g of raw liquorice. According to the invention, a medicated bath mode is adopted, so that medicines penetrate through the skin and enter capillary vessels, and blood circulation is promoted, thereby achieving the effects of promoting diuresis and removing jaundice; meanwhile, gastrointestinal tract peristalsis can be promoted, gastrointestinal hormone secretion is increased, milk intake is promoted, defecation is promoted and increased, and bilirubin hepatobiliary circulation is reduced.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine preparations, in particular to a bath preparation for preventing and treating neonatal jaundice. Background technique [0002] Neonatal jaundice refers to a disease characterized by jaundice on the skin, mucous membranes and sclera due to abnormal bilirubin metabolism in the neonatal period, which is characterized by jaundice in the skin, mucous membranes and sclera. It is divided into physiological jaundice and pathological jaundice. The most common symptoms can be seen in more than 50% of full-term infants and more than 80% of premature infants, accounting for 20% to 40% of hospitalized newborns. Physiological process, a small number of skin, mucous membranes and sclera yellow stains may occur due to the accumulation of bilirubin in the body. Although most neonatal jaundice has a good prognosis, some severe cases may develop bilirubin encephalopathy, which will damage the kidneys and ...

AI Technical Summary

Problems solved by technology

[0003] At present, the diagnosis and treatment guidelines for neonatal jaundice issued by pediatric associations around the world mainly include phototherapy, exchange transfusion and drugs. There are many contradictions in whether to intervene, the timing of intervention, and the intervention method, and it is very easy to over-treat or delay treatment. , in which phototherapy will lead to mother-infant separation, affect breastfeeding, and may have adverse reactions such as fever, dehydration, rash, mild diarrhea, damage to DNA molecules, damage to the retina, and increase the financial burden of the family of the child; Complications of exchange transfusion therapy Many, prone to the risk of blood-borne infectious diseases, and troublesome, expensive; and drug treatment is slow onset, weak effect, application indications are difficult to grasp, treatment drugs such as glucocorticoids, phenobarbital, clofibrate, etc. Often accompanied by different degrees of adverse reactions, the above treatments are difficult to achieve precise treatment at the grassroots level